74.35
-0.29 (-0.39%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Prestige Consumer Healthcare In | Bullish | Bullish |
Stockmoo Score
|
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Core |
| 52 Weeks Range | ||
| Median | 95.00 (27.77%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| DA Davidson | 28 Aug 2024 | 95.00 (27.77%) | Buy | 73.70 |
| 09 Aug 2024 | 93.00 (25.08%) | Buy | 66.25 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 03 Sep 2024 | Announcement | Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference |
| 08 Aug 2024 | Announcement | Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results |
| 02 Jul 2024 | Announcement | Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |